Association between fentanyl treatment for acute pain in the emergency department and opioid use two weeks after discharge.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 20 10 2021
revised: 23 11 2021
accepted: 29 11 2021
pubmed: 19 12 2021
medline: 27 1 2022
entrez: 18 12 2021
Statut: ppublish

Résumé

Analgesia with fentanyl can be associated with hyperalgesia (higher sensitivity to pain) and can contribute to escalating opioid use. Our objective was to assess the relationship between emergency department (ED) acute pain management with fentanyl compared to other opioids, and the quantity of opioids consumed two-week after discharge. We hypothesized that the quantity of opioids consumed would be higher for patients treated with fentanyl compared to those treated with other opioids. Patients were selected from two prospective cohorts assessing opioids consumed after ED discharge. Patients ≥18 years treated with an opioid in the ED for an acute pain condition (≤2 weeks) and discharged with an opioid prescription were included. Patients completed a 14-day paper or electronic diary of pain medication use. Quantity of 5 mg morphine equivalent tablets consumed during a 14-day follow-up by patients treated with fentanyl compared to those treated with other opioids during their ED stay were analyzed using a multiple linear regression and propensity scores. We included 707 patients (mean age ± SD: 50 ± 15 years, 47% women) in this study. During follow-up, patients treated with fentanyl (N = 91) during their ED stay consumed a median (IQR) of 5.8 (14) 5 mg morphine equivalent pills compared to 7.0 (14) for those treated with other opioids (p = 0.05). Results were similar using propensity score sensitivity analysis. However, after adjusting for confounding variables, ED fentanyl treatment showed a trend, but not a statistically significant association with a decreased opioid consumption during the 14-day follow-up (B = -2.4; 95%CI = -5.3 to 0.4; p = 0.09). Patients treated with fentanyl during ED stay did not consume more opioids after ED discharge, compared to those treated with other opioids. If fentanyl does cause more hyperalgesia compared to other opioids, it does not seem to have a significant impact on opioid consumption after ED discharge.

Sections du résumé

BACKGROUND BACKGROUND
Analgesia with fentanyl can be associated with hyperalgesia (higher sensitivity to pain) and can contribute to escalating opioid use. Our objective was to assess the relationship between emergency department (ED) acute pain management with fentanyl compared to other opioids, and the quantity of opioids consumed two-week after discharge. We hypothesized that the quantity of opioids consumed would be higher for patients treated with fentanyl compared to those treated with other opioids.
METHODS METHODS
Patients were selected from two prospective cohorts assessing opioids consumed after ED discharge. Patients ≥18 years treated with an opioid in the ED for an acute pain condition (≤2 weeks) and discharged with an opioid prescription were included. Patients completed a 14-day paper or electronic diary of pain medication use. Quantity of 5 mg morphine equivalent tablets consumed during a 14-day follow-up by patients treated with fentanyl compared to those treated with other opioids during their ED stay were analyzed using a multiple linear regression and propensity scores.
RESULTS RESULTS
We included 707 patients (mean age ± SD: 50 ± 15 years, 47% women) in this study. During follow-up, patients treated with fentanyl (N = 91) during their ED stay consumed a median (IQR) of 5.8 (14) 5 mg morphine equivalent pills compared to 7.0 (14) for those treated with other opioids (p = 0.05). Results were similar using propensity score sensitivity analysis. However, after adjusting for confounding variables, ED fentanyl treatment showed a trend, but not a statistically significant association with a decreased opioid consumption during the 14-day follow-up (B = -2.4; 95%CI = -5.3 to 0.4; p = 0.09).
CONCLUSIONS CONCLUSIONS
Patients treated with fentanyl during ED stay did not consume more opioids after ED discharge, compared to those treated with other opioids. If fentanyl does cause more hyperalgesia compared to other opioids, it does not seem to have a significant impact on opioid consumption after ED discharge.

Identifiants

pubmed: 34922233
pii: S0735-6757(21)00960-8
doi: 10.1016/j.ajem.2021.11.041
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Fentanyl UF599785JZ

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-142

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There is no financial benefit or conflict of interest to report from all co-authors.

Auteurs

Raoul Daoust (R)

Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Département Médecine de Famille et Médecine d'Urgence, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada; Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada. Electronic address: raoul.daoust@umontreal.ca.

Jean Paquet (J)

Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Centre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal (CIUSSS du Nord de-l'Île-de-Montréal), Montréal, Québec, Canada.

Verilibe Huard (V)

Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Département Médecine de Famille et Médecine d'Urgence, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada.

Jean-Marc Chauny (JM)

Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Département Médecine de Famille et Médecine d'Urgence, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada; Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada.

Gilles Lavigne (G)

Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Faculties of Dental Medicine and Medicine, Université de Montréal, Montréal, Québec, Canada.

David Williamson (D)

Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada.

Manon Choinière (M)

Department of Anesthesiology and Pain Medicine, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Eddy Lang (E)

Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Justin W Yan (JW)

Division of Emergency Medicine, Department of Medicine, Western University, London Health Sciences Centre, London, Ontario, Canada.

Jeffrey J Perry (JJ)

Department of Emergency Medicine, University of Ottawa, Clinical Epidemiology Unit, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Marcel Emond (M)

Département Médecine de Famille et Médecine d'Urgence, Faculté de Médecine, Université Laval, Québec, Canada; Département d'urgence du Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada.

Sophie Gosselin (S)

Department of Emergency Medicine, CISSS Montérégie-Centre, Greenfield Park, Québec, Canada.

Alexis Cournoyer (A)

Department of Emergency Medicine, Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada; Département Médecine de Famille et Médecine d'Urgence, Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada; Research Centre, CIUSSS-Nord-de-l'Île de-Montréal, Hôpital Sacré-Cœur de Montréal, Montréal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH